SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against RLX Technology Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

THE ANGEL–(BUSINESS WIRE) – Schall Law Firm, a national shareholder law firm, has announced that it has filed a class action lawsuit against RLX Technology Inc. (“RLX” or “the Company”) (NYSE: RLX) for violating US securities laws.

Investors who acquired and / or attributed to the Company’s shares in accordance with the Company’s initial public offering on January 22, 2021 (the “IPO”) are encouraged to contact the Company before August 9, 2021.

If you are a shareholder who has suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall law firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights free of charge. You can also contact us on the firm’s website at www.schallfirm.com or by email at [email protected]

In this case, the class has not yet been certified and you will not be represented by a lawyer until certified. If you do nothing, you can remain an absent class member.

According to the lawsuit, the company provided false and misleading information to the market. RLX has misrepresented and omitted facts in its bid documents related to the Chinese government’s campaign to create a national standard for e-cigarettes that would bring them in line with traditional tobacco products such as cigarettes. The company’s financial results were not as strong as projected in the offer documents and were not indicative of future performance. As a result of these facts, the offer documents were incorrect and materially misleading. When the market learned the truth about RLX, investors suffered damage.

Join the case to make up for your losses.

The law firm Schall represents investors worldwide and specializes in securities class actions and shareholder disputes.

This news release may be viewed as a solicitation in some jurisdictions under applicable law and ethical rules.

Comments are closed.